1 - 25 of 5
Number of results to display per page
TitleCreatorDate
1 Neuro-Ophthalmic Manifestations of Pituitary CarcinomaEmily A. Chang, BS; Ravi Shah, MD; Stacy V. Smith, MD; Ama Sadaka, MD; Juan Ortiz Gomez, MD; Patricia Chevez-Barrios, MD; Andrew G. Lee, MD2018-09
2 Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of VisionPeter M. K. de Blank, MD, MSCE; Michael J. Fisher, MD; Grant T. Liu, MD; David H. Gutmann, MD, PhD; Robert Listernick, MD; Rosalie E. Ferner, MD; Robert A. Avery, DO, MSCE2017-09
3 Optic Disc Metastasis as the Presenting Sign of Lung AdenocarcinomaJonathan A. Micieli, MD, CM; Edward A. Margolin, MD2016-12
4 Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment TrialMartin W. ten Hove, MD; Deborah I. Friedman, MD; Anil D. Patel, MD; Isabella Irrcher, PhD; Michael Wall, MD; Michael P. McDermott, PhD; for the NORDIC Idiopathic Intracranial Hypertension Study Group2016-03
5 Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment TrialKimberly E. Cello, BS; John L. Keltner, MD; Chris A. Johnson, PhD; Michael Wall, MD for the NORDIC Idiopathic Intracranial Hypertension Study Group2016-03
1 - 25 of 5